SCHEMBL2837126

SCHEMBL2837126

CN1CCC(Oc2ccc3ccccc3c2)c2occc2C1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 3/20 0.39
DRD3 P35462 1/20 0.39
DDB1 Q16531 1/20 0.38
CRBN Q96SW2 1/20 0.38
CHRNA3 P32297 1/20 0.36
HTR3A P46098 1/20 0.36
SLC6A2 P23975 3/20 0.36
SLC6A4 P31645 3/20 0.36
SLC6A3 Q01959 3/20 0.36
HPGD P15428 1/20 0.35
TSHR P16473 1/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
FPR2 P25090 1/20 0.35
PROKR1 Q8TCW9 1/20 0.35
KDM4E B2RXH2 1/20 0.35
MEN1 O00255 1/20 0.35
ALDH1A1 P00352 1/20 0.35
MAPT P10636 1/20 0.35
HTT P42858 1/20 0.35
KMT2A Q03164 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2836692 0.83 ROCK2 (0.34) HRH3CHRNA3ALDH1A1DRD1DRD5
SCHEMBL2838001 0.83 KDM4E (0.38) CHRNA3SLC6A2SLC6A4SLC6A3FPR2
SCHEMBL2844196 0.81 DDB1 (0.38) HRH3DRD3DDB1CRBNCHRNA3
SCHEMBL2838429 0.80 KMT2A (0.39) HRH3SLC6A2SLC6A4SLC6A3TSHR
SCHEMBL2841757 0.80 KMT2A (0.39) HRH3SLC6A2SLC6A4SLC6A3TSHR
Hydrochloric Acid SCHEMBL2842975 0.79 KMT2A (0.40) HRH3SLC6A2SLC6A4SLC6A3TSHR
SCHEMBL2841183 0.79 HTR2A (0.40) HRH3SLC6A4SMN1; SMN2FPR2PROKR1
SCHEMBL2840421 0.76 PKM (0.34) SLC6A2SLC6A4SLC6A3
SCHEMBL2839108 0.73 SIGMAR1 (0.36) DRD3HPGDSMN1; SMN2KDM4EMEN1
SCHEMBL2836674 0.73 DDB1 (0.38) HRH3DRD3DDB1CRBNCHRNA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8217031-B2 Heteroaryl derivatives NIPPON SHINYAKU CO., LTD. (JP) 2012-07-10 US disclosed
US-20100048537-A1 HETEROARYL DERIVATIVES NIPPON SHINYAKU CO., LTD. (JP) 2010-02-25 US disclosed
EP-2141168-A1 HETEROARYL DERIVATIVES Nippon Shinyaku Co., Ltd. (JP) 2010-01-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100048537-A1 HETEROARYL DERIVATIVES OPRD1, OPRM1, OPRK1 HRH3 777/4885DRD3 83/4885DDB1 3904/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.